Sundrug Co.,Ltd. (SDGCF)

Sundrug Co.,Ltd. (SDGCF) Healthcare & Pipeline Overview

Sundrug Co., Ltd., a Japanese retailer, operates drug and discount stores offering pharmaceuticals, cosmetics, food, and household goods. With a market capitalization of $3.62B and a P/E ratio of 14.0, Sundrug distinguishes itself through a broad product portfolio and a widespread store network across Japan.

What Is the Investment Thesis for SDGCF?

Sundrug Co., Ltd. presents a stable investment profile, characterized by its established retail presence and diverse product offerings in the Japanese market. The company's P/E ratio of 14.0 suggests a reasonable valuation compared to its earnings, while a dividend yield of 3.26% offers an income component for investors. A low beta of 0.06 indicates that the stock is less volatile than the overall market. Growth catalysts include potential expansion of its store network and increased demand for healthcare and consumer products in Japan. However, investors may want to evaluate risks such as competition from other retailers and potential changes in consumer spending patterns. The company's profit margin of 3.7% and gross margin of 25.6% reflect its profitability and operational efficiency.

Based on FMP financials and quantitative analysis

SDGCF Key Highlights

• Market capitalization of $3.62B, reflecting its significant presence in the Japanese retail market.
• P/E ratio of 14.0, indicating a potentially reasonable valuation compared to its earnings.
• Dividend yield of 3.26%, offering an income component for investors.
• Low beta of 0.06, suggesting lower volatility compared to the overall market.
• Gross margin of 25.6%, reflecting its ability to manage production costs and pricing strategies.

Who Are SDGCF's Competitors?

SDGCF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SDGCF's Key Strengths?

• Established brand and reputation in the Japanese market.
• Diverse product offerings across drug stores and discount stores.
• Widespread store network providing convenient access for customers.
• Stable financial performance with consistent profitability.

What Are SDGCF's Weaknesses?

• Relatively low profit margin compared to some competitors.
• Limited international presence.
• Dependence on the Japanese market.
• Potential vulnerability to changes in consumer spending patterns.

What Could Drive SDGCF Stock Higher?

• Expansion of store network in Japan to increase market presence.
• Enhancement of e-commerce platform to cater to online shoppers.
• Potential development of new private label products to improve profitability.
• Strategic alliances and partnerships to expand product offerings and reach.
• Focus on healthcare services to cater to the aging population.

What Are the Key Risks for SDGCF?

• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Intense competition from other retailers in the Japanese market.
• Changes in government regulations affecting the healthcare and retail sectors.
• Economic downturns impacting consumer spending.
• Fluctuations in currency exchange rates affecting import costs.
• Limited financial disclosure due to OTC listing.

What Are the Growth Opportunities for SDGCF?

• Expansion of Store Network: Sundrug can expand its market presence by opening new stores in underserved regions of Japan. The Japanese retail market is characterized by regional disparities, with some areas having a higher concentration of retail outlets than others. By strategically locating new stores in these underserved regions, Sundrug can tap into new customer bases and increase its overall market share. This expansion strategy could target both urban and rural areas, adapting the store format and product offerings to suit the specific needs of each location. The timeline for this expansion could be phased over the next 3-5 years, with a target of opening 10-15 new stores per year.
• Enhancement of E-commerce Platform: Sundrug can enhance its e-commerce platform to cater to the growing demand for online shopping in Japan. The e-commerce market in Japan has been experiencing rapid growth, driven by increasing internet penetration and changing consumer behavior. By investing in its online platform, Sundrug can reach a wider customer base, offer greater convenience, and improve customer engagement. This enhancement could include features such as personalized recommendations, online ordering and delivery, and mobile app integration. The timeline for this enhancement could be implemented over the next 1-2 years, with a focus on improving user experience and expanding product offerings.
• Development of Private Label Products: Sundrug can develop and expand its range of private label products to improve profitability and differentiate itself from competitors. Private label products typically offer higher profit margins compared to branded products, allowing retailers to improve their overall profitability. By developing its own line of private label products, Sundrug can also create a unique brand identity and build customer loyalty. These products could include pharmaceuticals, health and beauty items, and household goods. The timeline for this development could be phased over the next 2-3 years, with a focus on quality, value, and customer satisfaction.
• Strategic Alliances and Partnerships: Sundrug can form strategic alliances and partnerships with other companies to expand its product offerings and reach new markets. These alliances could include partnerships with pharmaceutical companies, healthcare providers, and other retailers. By collaborating with other companies, Sundrug can leverage their expertise, resources, and distribution networks to enhance its competitive position and drive growth. For example, Sundrug could partner with a pharmaceutical company to develop and market new drugs, or with a healthcare provider to offer integrated healthcare services. The timeline for these alliances could be ongoing, with a focus on identifying mutually beneficial opportunities.
• Focus on Healthcare Services: Sundrug can expand its focus on healthcare services by offering a wider range of services in its drug stores and pharmacies. The demand for healthcare services in Japan is increasing, driven by an aging population and growing awareness of health and wellness. By offering services such as health checkups, medication counseling, and disease management programs, Sundrug can attract new customers and build stronger relationships with existing customers. This expansion could also include the integration of technology, such as telemedicine and remote monitoring, to improve access to healthcare services. The timeline for this expansion could be phased over the next 3-5 years, with a focus on providing high-quality, patient-centered care.

What Opportunities Does SDGCF Have?

• Expansion of e-commerce platform to reach a wider customer base.
• Development of private label products to improve profitability.
• Strategic alliances and partnerships to expand product offerings.
• Focus on healthcare services to cater to the aging population.

What Threats Does SDGCF Face?

• Intense competition from other retailers in the Japanese market.
• Potential changes in government regulations affecting the healthcare and retail sectors.
• Economic downturns impacting consumer spending.
• Fluctuations in currency exchange rates affecting import costs.

What Are SDGCF's Competitive Advantages?

• Established retail presence in Japan with a widespread store network.
• Diverse product offerings catering to a wide range of consumer needs.
• Strong brand recognition and customer loyalty.
• Efficient supply chain and distribution network.

What Does SDGCF Do?

Founded in 1957 and headquartered in Fuchu, Japan, Sundrug Co., Ltd. has evolved into a prominent operator of drug stores and discount stores throughout Japan. The company's business spans a diverse range of products, including pharmaceuticals, cosmetics, home appliances, clothing, car supplies, sports goods, alcoholic beverages, and fresh food. This extensive product offering allows Sundrug to cater to a wide customer base and meet various consumer needs. Sundrug's operations are divided into two primary segments: drug stores and discount stores. The drug stores focus on providing pharmaceutical products, health and beauty items, and over-the-counter medications, often including dispensing pharmacies. The discount stores offer a broader selection of products at competitive prices, attracting customers seeking value and convenience. With a workforce of 6662 employees, Sundrug maintains a significant retail presence across Japan. The company's strategy involves expanding its store network, enhancing its product offerings, and improving operational efficiency to drive growth and profitability. Sundrug's commitment to providing quality products and services has solidified its position in the Japanese retail market.

What Products and Services Does SDGCF Offer?

• Operates drug stores offering pharmaceuticals, health and beauty products, and over-the-counter medications.
• Manages dispensing pharmacies providing prescription medications and pharmaceutical services.
• Runs discount stores selling a wide range of products, including food, cosmetics, and household goods.
• Offers home appliances, clothing, car supplies, and sports goods in its discount stores.
• Sells alcoholic beverages and fresh food in select locations.
• Provides kerosene and other seasonal products.

How Does SDGCF Make Money?

• Generates revenue through the sale of pharmaceutical products and healthcare-related items in its drug stores.
• Earns income from the sale of a diverse range of products in its discount stores.
• Profits from dispensing prescription medications and providing pharmaceutical services in its pharmacies.
• Utilizes a retail network of drug and discount stores to reach customers across Japan.

What Industry Does SDGCF Operate In?

Sundrug Co., Ltd. operates within the competitive Japanese retail market, which includes drug stores, discount stores, and supermarkets. The healthcare and retail sectors in Japan are influenced by factors such as an aging population, increasing healthcare awareness, and evolving consumer preferences. The market is characterized by intense competition, with players like ANSLF, BUGDF, BUHPF, MAHLY, and MEPDF vying for market share. Sundrug differentiates itself through its diverse product offerings and widespread store network. The Japanese retail market is expected to grow steadily, driven by increasing consumer spending and demand for healthcare products and services.

Who Are SDGCF's Key Customers?

• Individuals seeking pharmaceutical products and healthcare-related items.
• Consumers looking for a wide range of products at competitive prices.
• Patients requiring prescription medications and pharmaceutical services.
• Households purchasing everyday essentials and household goods.

FY2026 estForward Outlook

Wall Street analysts project Sundrug Co.,Ltd. revenue of about $847.28B for fiscal 2026, with EPS near $1.69. The estimate reflects 7 contributing analysts.

SDGCF Valuation & Market Position

With a $3.62B market cap, Sundrug Co.,Ltd. sits in the mid-cap segment of the market. Relative to its peer group, SDGCF's quantitative score of 48/100 is roughly in line with the peer average of 49/100.

ROE 11%Key Financial Metrics

Return on equity for Sundrug Co.,Ltd. stands at 11.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.6%, showing how much profit it generates from its asset base. SDGCF trades at a trailing price-to-earnings ratio of 13.98, below the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.78 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 7.1%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 3/9Financial Health

Sundrug Co.,Ltd.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 4.83 places it in the safe zone, indicating low near-term bankruptcy risk.

Company Profile

Sundrug Co.,Ltd. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Fuchu, JP. The company is led by CEO Hiroshi Sadakata. SDGCF has traded publicly since 2014.

SDGCF Financials

SDGCF Latest News

No recent news available for SDGCF.

SDGCF Analyst Consensus

SDGCF MoonshotScore

What Investors Ask About Sundrug Co.,Ltd. (SDGCF) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources